The ventilator-associated pneumonia PIRO score: A tool for predicting ICU mortality and health-care resources use in ventilator-associated pneumonia

Chest

Volumn 134, Issue 6, 2008, Pages 1208-1216

  Lisboa, Thiago ^a   Diaz, Emili ^a   Sa Borges, Marcio ^b   Socias, Antonia ^b   Sole Violan, Jordi ^c   Rodríguez, Alejandro ^a   Rello, Jordi ^a  

^a HOSPITAL UNIVERSITARI JOAN XXIII   (Spain)

^b HOSPITAL SON LLÀTZER   (Spain)

^c Departments of Immunology and Microbiology   (Spain)

Author keywords

PIRO; Sepsis; Ventilator associated pneumonia

Indexed keywords

ANTIBIOTIC AGENT;

ADULT; AGED; ARTICLE; ARTIFICIAL VENTILATION; BACTEREMIA; CHRONIC KIDNEY FAILURE; CHRONIC OBSTRUCTIVE LUNG DISEASE; COHORT ANALYSIS; COMORBIDITY; CONTROLLED STUDY; DISEASE SEVERITY; FEMALE; HAZARD RATIO; HEALTH CARE; HEART FAILURE; HIGH RISK PATIENT; HUMAN; IMMUNE DEFICIENCY; INTENSIVE CARE UNIT; LIVER CIRRHOSIS; MAJOR CLINICAL STUDY; MALE; MORTALITY; PRIORITY JOURNAL; PROSPECTIVE STUDY; SCORING SYSTEM; SYSTOLIC BLOOD PRESSURE; VENTILATOR ASSOCIATED PNEUMONIA;

EID: 57349165386     PISSN: 00123692     EISSN: 19313543     Source Type: Journal    
DOI: 10.1378/chest.08-1106     Document Type: Article

References (42)

1. Rabe K, Hurd S, Anzueto A, et al. Global Strategy for the diagnosis, management, and prevention of Chronic Obstructive Pulmonary Disease (GOLD). Am J Respir Crit Care Med 2007; 176:532-555
2. Simonneau G, Galie N, Rubin LJ, et al. Clinical classification of pulmonary hypertension. J Am Coll Cardiol 2004; 43:5S-12S
3. Lim WS, van del Eerden MM, Laing R et al. Defining community acquired pneumonia severity on presentation to hospital: an international derivation and validation study. Thorax 2003; 58:377-378
4. Povoa P, Coelho L, Almeida E, et al. C-reactive protein as a marker of ventilator-associated pneumonia. Eur Respir J 2005; 25:804-812
5. Lisboa T, Seligman R, Diaz E, et al. CRP correlates with bacterial load and appropriate antibiotic therapy in suspected ventilator-associated pneumonia. Crit Care Med 2008; 36:166-171
6. Luyt CE, Guerin V, Combes A, et al. Procalcitonin kinetics as a prognostic marker of ventilator associated pneumonia. Am J Respir Crit Care Med 2005; 171:48-53
7. Levy MM, Fink MP, Marshall JC, et al. 2001 SCCM/ESICM/ACCP/ATS/SIS international sepsis definitions conference. Crit Care Med 2003; 31:1250-1256
8. Moreno R, Metnitz B, Adler L, et al. Sepsis mortality prediction based on predisposition, infection and response. Intensive Care Med 2008; 34:496-504
9. American Thoracic Society. Guidelines for the management of adults with hospital-acquired, ventilator-associated and healthcare-associated Pneumonia. Am J Respir Crit Care Med 2005; 171:388-416
10. Kollef M, Morrow L, Niederman M, et al. Clinical characteristics and treatment patterns among patients with ventilator-associated pneumonia. Chest 2006; 129:1210-1218
11. Rello J, Ollendorf DA, Oster G, et al. Epidemiology and outcomes of ventilator-associated pneumonia in a large US database. Chest 2002; 122:2115-2121
12. Agbaht K, Diaz E, Muñoz E, et al. Bacteremia in patients with ventilator-associated pneumonia is associated with increased mortality: a study comparing bacteremic vs nonbacteremic ventilator associated pneumonia. Crit Care Med 2007; 35:2064-2070
13. Agbaht K, Lisboa T, Pobo A, et al. Management of ventilator-associated pneumonia in a multidisciplinary intensive care unit: does trauma make a difference? Intensive Care Med 2007; 33:1387-1395
14. Kollef MH. Ventilator-associated pneumonia: a multivariate analysis. JAMA 1993; 270:1965-1970
15. Rello J, Rodríguez A, Torres A et al. Implications of COPD in patients admitted to the intensive care unit by community-acquired pneumonia. Eur Respir J 2006; 27:1210-1216
16. Dellinger RP, Carlet JM, Masur H, et al. Surviving Sepsis Campaign guidelines for management of severe sepsis and septic shock. Crit Care Med 2004; 32:858-873
17. Bernard GR, Artigas A, Brigham KL et al. The American-European Consensus Conference on ARDS: definitions, mechanisms, relevant outcomes, and clinical trial coordination. Am J Respir Crit Care Med 1994; 149:818-824
18. Kollef MH, Rello J, Cammarata SK, et al. Clinical cure and survival in Gram-positive ventilator-associated pneumonia: retrospective analysis of two double-blind studies comparing linezolid with vancomycin. Intensive Care Med 2004; 30:388-394
19. Wunderink RG. Therapy for nosocomial pneumonia. Curr Opin Pulm Med 1997; 3:120-124
20. Hanley J, McNeil B. The meaning and the use of the area under a receiver operating characteristics (ROC) curve. Radiology 1982; 143:29-36
21. Angus DC, Burgner D, Wunderink R, et al. The PIRO concept: P is for predisposition. Crit Care 2003; 7:248-251
22. Vincent JL, Opal S, Torres A, et al. The PIRO concept: I is for infection. Crit Care 2003; 7:252-255
23. Gerlach H, Dhainaut JF, Harbarth S, et al. The PIRO concept: R is for response. Crit Care 2003; 7:256-259
24. Vincent JL, Wendon J, Groeneveld J, et al. The PIRO concept: O is for organ dysfunction. Crit Care 2003; 7:260-264
25. Luna CM, Blanzaco D, Niederman MS, et al. Resolution of ventilator-associated pneumonia: prospective evaluation of the clinical pulmonary infection score as an early clinical predictor of outcome. Crit Care Med 2003; 31:676-682
26. Vidaur L, Sirgo G, Rodriguez A, et al. Clinical approach to the patient with suspected ventilator-associated pneumonia. Respir Care 2005; 50:965-974
27. Rello J, Rué M, Jubert P, et al. Survival in patients with nosocomial pneumonia: impact of the severity of illness and the etiologic agent. Crit Care Med 1997; 25:1862-1867
28. Luna CM, Aruj P, Niederman MS, et al. Appropriateness and delay to initiate therapy in ventilador-associated pneumonia. Eur Respir J 2006; 27:158-164
29. Clec'h C, Timsit JF, Lassence A, et al. Efficacy of adequate early antibiotic therapy in ventilator-associated pneumonia: influence of disease severity. Intensive Care Med 2004; 30:1327-1333
30. Hedrick T, Smith R, McElearney S, et al. Difference in early- and late-onset ventilator-associated pneumonia between surgical and trauma patients in a combined surgical or trauma intensive care unit. J Trauma 2008; 64:714-720
31. Eckert MJ, Davis KA, Reed RL, et al. Ventilator-associated pneumonia, like real estate: location really matters. J Trauma 2006; 60:104-110
32. Rello J, Quintana E, Ausina V, et al. Incidence, etiology and outcome of nosocomial pneumonia in mechanically ventilated patients. Chest 1991; 100:439-444
33. Trouillet J, Chastre J, Vuagnat A, et al. Ventilator-associated pneumonia caused by potentially drug-resistant bacteria. Am J Respir Crit Care Med 1998; 157:531-539
34. Valles J, Pobo A, Garcia-Esquirol O, et al. Excess ICU mortality attributable to ventilator-associated pneumonia: the role of early vs late onset. Intensive Care Med 2007; 33:1363-1368
35. Croce M, Swanson J, Magnotti L, et al. The futility of the clinical pulmonary infection score in trauma patients. J Trauma 2006; 60:523-527
36. Timsit J, Chevret S, Valcke J, et al. Mortality of nosocomial pneumonia in ventilated patients: influence of diagnostic tools. Am J Respir Crit Care Med 1996; 154:116-123
37. Cunnion K, Weber D, Broadhead W, et al. Risk factors for nosocomial pneumonia: comparing adult critical care populations. Am J Respir Crit Care Med 1996; 153:158-162
38. Heyland D, Cook D, Griffith L, et al. The attributable morbidity and mortality of ventilator-associated pneumonia in the critically ill patient. Am J Respir Crit Care Med 1999; 159:1249-1256
39. Kollef M, Silver P, Murphy D, et al. The effect of late-onset ventilator-associated pneumonia in determining patient mortality. Chest 1995; 108:1655-1662
40. Baker A, Meredith J, Haponik E. Pneumonia in intubated trauma patients microbiology and outcomes. Am J Respir Crit Care Med 1996; 153:343-349
41. Vincent JL, Moreno R, Takala J, et al. The SOFA (Sepsis-related Organ Failure Assessment) score to describe organ dysfunction/failure. Intensive Care Med 1996; 22:707-710
42. Heyland D, Cook D, Dodek P, et al. A randomized trial of diagnostic techniques for ventilator-associated pneumonia. N Engl J Med 2006; 355:2619-2630